Have you read any filings before? Going concern and bankruptcy is always on the table for companies lacking revenue. Humanigen still doesn’t have a commercially viable product in Lenz, it may be viable in the future, and most likely will be, but it ain’t right now. From a disclosure perspective it’s always best to go with the worst case scenario and that’s what the lawyers tell them to do.
There is way more going on in the background if you read between the lines. I read between those lines and bought almost 600k shares yesterday before the close. I rolled the dice like I did after the Kalobios bankruptcy when I bought shares at .30 cents to eventually sell at over $5.
We probably aren’t going to see that again where we are at, but I bet we will see these shares trading at least close to a dollar with any sniff of a plan for someone to take the shell and Lenz to the next level.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.